CoChat

Defining Surgical Indications for Type I Gastric Carcinoid Tumor

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

Background Most gastric carcinoid tumors (GC) (type I) occur in association with achlorhydria, hypergastrinemia, atrophic gastritis and exhibit low-grade histopathology. The management of this indolent disease is controversial. The aim of this study was to evaluate endoscopic surveillance (ES) compare with surgical resection (SR) for type I GC.Methods Between 1985 and 2007, 65 patients with type IGC were identified. Data analysis included: demographics, biochemical and endoscopic assessment, type of operation performed, and pathologic evaluation. The primary endpoints were disease-specific survival (DSS) in both groups and recurrence-free survival (RFS) in SR patients.Results Median follow-up was 30 months (range 1-176 months); most patients were female (83%) with median age of 58 years (range 29-91 years). Type I GC was diagnosed by evidence of hypergastrinemia and/or positive autoimmune antibodies with histopathologic confirmation. Patients underwent ES with polypectomy (n=46) or gastric resection (n=19). SR was performed with larger tumor size, increased depth of invasion, and solitary tumors. Although the 5-year RFS in SR patients was 75%, the DSS in both groups was 100%. However, concomitant adenocarcinoma was identified in 4/19 resected cases; 2/4 were detected on preoperative biopsies. All cases with coexisting gastric adenocarcinoma had larger carcinoid tumors and more advanced carcinoid disease.Conclusions The DSS is excellent for type I GC patients treated with either ES or SR. SR should be considered with more advanced carcinoid disease given its association with an increased risk of adenocarcinoma. ES is appropriate to assess both the status of carcinoid disease and dysplasia or adenocarcinoma that can develop in association with type I GC.

Overview

Integrity signals

Registry

Crossref · 10.1245/s10434-009-0687-y

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 37 references

Research works printed but not linked: 1

  1. Hamilton SR, Aaltonen LA. World Health Organization classification of tumors, pathology and genetics of tumors of the digestive system. Lyon: IARC; 2000.

Cited by

See all 112

Metadata

Authors
Gladdy, R. A., Strong, V. E., Coit, D., Allen, P. J., Gerdes, H., Shia, J., Klimstra, D. S., Brennan, M. F., & Tang, L. H.
Affiliations
Memorial Sloan Kettering Cancer Center (US)
Corresponding author
Tang, Laura H.
Venue
Annals of Surgical Oncology
Published
2009-09-01
Volume
16
Issue
11
Pages
3154-3160
ISSN
  • 1068-9265 (ISSN-L)
  • 1534-4681
OpenAlex
W2132350514
Cited by
112
References
36
Citations by year
2026: 2 · 2025: 9 · 2024: 4 · 2023: 6 · 2022: 4 · 2021: 11 · 2020: 10 · 2019: 9 · 2018: 5 · 2017: 7 · 2016: 7 · 2015: 7 · 2014: 6 · 2013: 6 · 2012: 5
FWCI
4.25
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Annals of Surgical Oncology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
  • Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal Tumor Research and Treatment
Keywords
surgical indications, endoscopic surveillance, surgical resection, gastric resection, polypectomy, disease-specific survival, recurrence-free survival, gastric adenocarcinoma, hypergastrinemia, achlorhydria, atrophic gastritis, dysplasia
MeSH terms
Adenocarcinoma, Adult, Aged, Aged, 80 and over, Carcinoid Tumor, Female, Follow-Up Studies, Gastroscopy, Humans, Male, Middle Aged, Neoplasm Staging, Prognosis, Prospective Studies, Stomach Neoplasms, Survival Rate, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Defining Surgical Indications for Type I Gastric Carcinoid Tumor. https://app.cochat.ai/papers/10.1245/s10434-009-0687-y
The paper
Gladdy, R. A., Strong, V. E., Coit, D., Allen, P. J., Gerdes, H., Shia, J., Klimstra, D. S., Brennan, M. F., & Tang, L. H. (2009). Defining Surgical Indications for Type I Gastric Carcinoid Tumor. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-009-0687-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.